Cargando…

Preliminary characterization of IL32 in basal-like/triple negative compared to other types of breast cell lines and tissues

BACKGROUND: Triple negative breast cancer (TNBC) and often basal-like cancers are defined as negative for estrogen receptor, progesterone receptor and Her2 gene expression. Over the past few years an incredible amount of data has been generated defining the molecular characteristics of both cancers....

Descripción completa

Detalles Bibliográficos
Autores principales:	Player, Audrey, Oguamanam, Tim, Okanmelu, Jennifer, Burrell, Kayla, Hollomon, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132244/ https://www.ncbi.nlm.nih.gov/pubmed/25100201 http://dx.doi.org/10.1186/1756-0500-7-501

Ejemplares similares

Identification of candidate genes associated with triple negative breast cancer
por: Player, Audrey, et al.
Publicado: (2017)

Maspin expression is frequent and correlates with basal markers in triple-negative breast cancer
por: Umekita, Yoshihisa, et al.
Publicado: (2011)

ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer
por: van Geldermalsen, M, et al.
Publicado: (2016)

Are Basal-Like and Non-Basal-Like Triple-Negative Breast Cancers Really Different?
por: Dogra, Atika, et al.
Publicado: (2020)

Targeting EGFR in Triple Negative Breast Cancer
por: Ueno, Naoto T., et al.
Publicado: (2011)

Identification of the orphan gene Prod 1 in basal and other salamander families
por: Geng, Jie, et al.
Publicado: (2015)

Are triple-negative tumours and basal-like breast cancer synonymous?
por: Rakha, Emad A, et al.
Publicado: (2007)

The Epigenetics of Triple-Negative and Basal-Like Breast Cancer: Current Knowledge
por: Temian, Daiana Cosmina, et al.
Publicado: (2018)

Triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival
por: Choi, Yoon-La, et al.
Publicado: (2010)

The Characterization of Cell Line Crl-2335 as a Basal-Like Breast Carcinoma Model
por: Hill Neves, Lori A., et al.
Publicado: (2011)

IL-32γ promotes the healing of murine cutaneous lesions caused by Leishmania braziliensis infection in contrast to Leishmania amazonensis
por: Gomes, Rodrigo Saar, et al.
Publicado: (2017)

Are triple-negative tumours and basal-like breast cancer synonymous? Authors' response
por: Kreike, Bas, et al.
Publicado: (2007)

p16 expression correlates with basal-like triple-negative breast carcinoma
por: Abou-Bakr, Amany A, et al.
Publicado: (2013)

Co-dependency for MET and FGFR1 in basal triple-negative breast cancers
por: Sung, Vanessa Y. C., et al.
Publicado: (2021)

Triple-negative and triple-positive breast cancer cells reciprocally control their growth and migration via the S100A4 pathway
por: Dukhanina, Elena A., et al.
Publicado: (2022)

Correction: triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival
por: Choi, Yoon-La, et al.
Publicado: (2011)

Establishment of highly invasive pancreatic cancer cell lines and the expression of IL-32
por: Takagi, Kohji, et al.
Publicado: (2020)

Tumor-Infiltrating Lymphocytes in Triple Negative Breast Cancer: The Future of Immune Targeting
por: García-Teijido, Paula, et al.
Publicado: (2016)

HPV infection and triple-negative breast cancers: an Italian case-control study
por: Piana, Andrea Fausto, et al.
Publicado: (2014)

Comparison of BRCA1 Expression between Triple-Negative and Luminal Breast Tumors
por: Darbeheshti, Farzaneh, et al.
Publicado: (2018)

Anti‐EGFR antibody‐drug conjugate for triple‐negative breast cancer therapy
por: Si, Yingnan, et al.
Publicado: (2020)

IL-32 and IL-34 in hepatocellular carcinoma
por: Si, Yang, et al.
Publicado: (2022)

Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas
por: Kreike, Bas, et al.
Publicado: (2007)

A clinically relevant gene signature in triple negative and basal-like breast cancer
por: Rody, Achim, et al.
Publicado: (2011)

Calpain system protein expression in basal-like and triple-negative invasive breast cancer
por: Storr, S. J., et al.
Publicado: (2012)

Modulatory Role of microRNAs in Triple Negative Breast Cancer with Basal-Like Phenotype
por: Angius, Andrea, et al.
Publicado: (2020)

Hypoxia Triggers TAZ Phosphorylation in Basal A Triple Negative Breast Cancer Cells
por: Liu, Qiuyu, et al.
Publicado: (2022)

Triple-negative breast cancer with brain metastases: a comparison between basal-like and non-basal-like biological subtypes
por: Niwińska, Anna, et al.
Publicado: (2011)

Integrity and Quantity Evaluation of Plasma Cell-Free DNA in Triple Negative Breast Cancer
por: Salimi, Mahdieh, et al.
Publicado: (2019)

SABCS 2020: update on triple-negative and metastatic HER2-positive breast cancer
por: Bartsch, Rupert
Publicado: (2021)

AR negative triple negative or “quadruple negative” breast cancers in African American women have an enriched basal and immune signature
por: Davis, Melissa, et al.
Publicado: (2018)

BCRP and P-gp relay overexpression in triple negative basal-like breast cancer cell line: a prospective role in resistance to Olaparib
por: Dufour, Robin, et al.
Publicado: (2015)

Effects of IL‐32 polymorphisms and IL‐32 levels on the susceptibility and severity of coronary artery disease
por: Jin, Susu, et al.
Publicado: (2021)

Reversal of HER2 Negativity: An Unexpected Role for Lovastatin in Triple-Negative Breast Cancer Stem Cells
por: Yi, Huimei, et al.
Publicado: (2020)

MiR-34b is associated with clinical outcome in triple-negative breast cancer patients
por: Svoboda, Marek, et al.
Publicado: (2012)

Adjuvant chemotherapy for resected triple negative breast cancer patients: A network meta-analysis
por: Petrelli, Fausto, et al.
Publicado: (2022)

Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype
por: Wiese, David A, et al.
Publicado: (2013)

Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype
por: Elsheikh, S E, et al.
Publicado: (2008)

Aberrant promoter methylation contributes to LRIG1 silencing in basal/triple-negative breast cancer
por: Umeh-Garcia, Maxine, et al.
Publicado: (2022)

Screening potential immune signatures for early-stage basal-like/triple-negative breast cancer
por: Wu, Min, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_03oqaove96dfpulsolppd3gq5d